Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia.

dc.contributor.author

Turner, Nicholas A

dc.contributor.author

Moehring, Rebekah

dc.contributor.author

Sarubbi, Christina

dc.contributor.author

Wrenn, Rebekah H

dc.contributor.author

Drew, Richard H

dc.contributor.author

Cunningham, Coleen K

dc.contributor.author

Fowler, Vance G

dc.contributor.author

Anderson, Deverick J

dc.date.accessioned

2018-04-02T18:09:16Z

dc.date.available

2018-04-02T18:09:16Z

dc.date.issued

2018-03

dc.date.updated

2018-04-02T18:09:15Z

dc.description.abstract

Penicillin allergy frequently impacts antibiotic choice. As beta-lactams are superior to vancomycin in treating methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, we examined the effect of reported penicillin allergy on clinical outcomes in patients with MSSA bacteremia.In this retrospective cohort study of adults with MSSA bacteremia admitted to a large tertiary care hospital, outcomes were examined according to reported penicillin allergy. Primary outcomes included 30-day and 90-day mortality rates. Multivariable regression models were developed to quantify the effect of reported penicillin allergy on mortality while adjusting for potential confounders.From 2010 to 2015, 318 patients with MSSA bacteremia were identified. Reported penicillin allergy had no significant effect on adjusted 30-day mortality (odds ratio [OR], 0.73; 95% confidence interval [CI], 0.29-1.84; P = .51). Patients with reported penicillin allergy were more likely to receive vancomycin (38% vs 11%, P < .01), but a large number received cefazolin regardless of reported allergy (29 of 66, 44%). Mortality rates were highest among nonallergic patients receiving vancomycin (22.6% vs 7.4% for those receiving beta-lactams regardless of reported allergy, P < .01). In multivariable analysis, beta-lactam receipt was most strongly associated with survival (OR, 0.26; 95% CI, 0.12-0.54).Reported penicillin allergy had no significant effect on 30- or 90-day mortality. Non-penicillin-allergic patients receiving vancomycin for treatment of MSSA bacteremia had the highest mortality rates overall. Receipt of a beta-lactam was the strongest predictor of survival. These results underscore the importance of correct classification of patients with penicillin allergy and appropriate treatment with a beta-lactam when tolerated.

dc.identifier.issn

2328-8957

dc.identifier.issn

2328-8957

dc.identifier.uri

https://hdl.handle.net/10161/16481

dc.language

eng

dc.publisher

Oxford University Press (OUP)

dc.relation.ispartof

Open forum infectious diseases

dc.relation.isversionof

10.1093/ofid/ofy042

dc.subject

bacteremia

dc.subject

methicillin-susceptible Staphylococcus aureus

dc.subject

penicillin allergy

dc.title

Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia.

dc.type

Journal article

duke.contributor.orcid

Turner, Nicholas A|0000-0003-0650-4894

duke.contributor.orcid

Moehring, Rebekah|0000-0001-7741-6029

duke.contributor.orcid

Drew, Richard H|0000-0003-0406-0804

duke.contributor.orcid

Cunningham, Coleen K|0000-0002-7725-3052

duke.contributor.orcid

Fowler, Vance G|0000-0002-8048-0897

duke.contributor.orcid

Anderson, Deverick J|0000-0001-6882-5496

pubs.issue

3

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Pathology

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Pediatrics, Infectious Diseases

pubs.organisational-group

Pediatrics

pubs.organisational-group

Medicine, Infectious Diseases

pubs.organisational-group

Medicine

pubs.organisational-group

Staff

pubs.publication-status

Published

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ofy042.pdf
Size:
175.89 KB
Format:
Adobe Portable Document Format
Description:
Accepted version